Sign in
Enrolling by invitationNo phase

Study on the Construction and Application of Early Warning Model of Sepsis in Critically Ill Patients

Key facts

Who runs it
Second Affiliated Hospital of Wenzhou Medical University
Where
China1 site in 1 countryChoose a country to see its sites
Trial code
Status
Enrolling by invitation
People taking part
100 people, planned
Started
1 Jan 2019
Planned end
30 Dec 2025
Type of study
Observational
Record updated
1 April 2025

Who can take part

Age
18 years to 99 years
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 12 criteriaShow less

Who can take part

  • Temperature > 38°C or < 36°C
  • Heart rate > 90 beats/min
  • Respiratory rate > 20 breaths/min or PaCO₂ < 32 mmHg
  • White blood cell count > 12.0 × 10⁹/L or < 4.0 × 10⁹/L, or > 10% immature neutrophils
  • Initial septic shock diagnosis
  • Organ dysfunction (cardiovascular, respiratory, or ≥ 2 other organs)
  • Complete clinical data

Who cannot take part

  • Chemotherapy
  • Radiotherapy
  • Cancer history
  • Controls were free of infectious or inflammatory diseases and glucocorticoid use
  • Incomplete data

The main criteria, as questions

Answer for yourself. This is not a decision: only the study team can say whether you can take part.

  • Are you between 18 and 99 years old?

This trial has no sites in United States.

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

The condition of sepsis patients changes rapidly, whom are often accompanied by impaired respiratory, circulatory, renal, and coagulation functions. So far, the prognosis of sepsis at home and abroad is not ideal. Participants was randomly included in this research project on the pathogenesis and prevention of sepsis due to typical sepsis symptoms. the investigators will collect appropriate clinical specimens for analysis of immune cell functions and pathogenic microorganisms combined with individual patient research. This study will enable sepsis patients to be identified early and receive earlier anti-sepsis treatment, which is expected to improve the prognosis of sepsis, shorten hospitalization time, and reduce treatment costs.

Read full original descriptionShow less

The above-mentioned tests and analyses do not increase the economic burden on the participants, and the required expenses are all paid from the project funds; they do not affect the prognosis and rehabilitation process of participants, and do not have adverse effects on the health of participants.

The group in the trial

  • sepsis and control

    The presence of sepsis at the time of admission to the ICU is called sepsis, and the absence of sepsis is called control.

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Criteria questions
Built from NCT06904001, who can take part
Record updated
1 April 2025